Report Scope
This study offers a global view of RNA analysis for various applications. This report analyzes and assesses different types of RNA analysis involved, namely microarrays, polymerase chain reaction (PCR), sequencing technologies, and RNAi gene silencing. It also provides information by application, categorized as clinical diagnosis, drug discovery and toxicogenomics.
The publisher analyzed and made projections for each market and its type, new products and technological advances. Also included in the report is a discussion of the impact of COVID-19 on the market and profiles of leading companies in the RNA analysis market. The leading firms in the market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Bio-Rad Laboratories, CD Genomics, Promega Corp., Illumina Inc., Qiagen NV, Danaher Corp., F. Hoffmann-La Roche Ltd., Merck KGaA, Fluidigm Corp., and Eurofins Scientific.
By region, this report is broken down into North America, Europe, Asia-Pacific, South America, and the Middle East and Africa (MEA).
The Report Includes
- 41 tables
- An overview of the global RNA analysis/transcriptomics market
- Analyses of global market trends, with data from 2019, 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Detailed analysis of the current market trends and forecast, relevant R&D activities, new products launches and product enhancement in the industry and discussion of regulatory elements that are affecting the future marketplace
- A detailed description of RNA analysis types such as microarrays, polymerase chain reaction (PCR), sequencing technologies, and RNAi gene silencing, and coverage of their industry structure
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Company profiles of major players in the market including Agilent Technologies Inc., Bio-Rad Laboratories Inc., CD Genomics, Danaher, Roche, Illumina Inc., Merck KGAA, Qiagen, Thermo Fisher Scientific Inc.
Table of Contents
Chapter 1 Introduction
- Scope of the Report
- Reasons for Doing This Study
- Information Sources
- Research Methodology
- Geographic Breakdown
- Analyst's Credentials
- Related Reports
Chapter 2 Summary and Highlights
Chapter 3 Overview
- Impact of COVID-19 on the Market for RNA Analysis/Transcriptomics
Chapter 4 Global Market for RNA Analysis/Transcriptomics
- Global Market for RNA Analysis/Transcriptomics
- Global Market for RNA Analysis/Transcriptomics by Technology
- Polymerase Chain Reaction
- Sequencing Technologies
- Microarrays
- RNAi Gene Silencing
- Global Market for RNA Analysis/Transcriptomics by Application
- Drug Discovery
- Toxicogenomics
- Clinical Diagnosis
- Global Market for RNA Analysis/Transcriptomics by Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East and Africa
Chapter 5 Drivers and Challenges
- Market Drivers
- Growing Research in Transcriptomics
- Increasing Research in Medicinal Plant Transcriptomics
- Market Challenges
- Working with Huge Volumes of Data
Chapter 6 Supplier Landscape, Company Share Analysis and Company Profiles
- Mergers and Acquisitions
- Company Share Analysis
- Company Profiles
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- CD Genomics
- Danaher Corp.
- Eurofins Scientific
- F. Hoffmann-La Roche Ltd.
- Fluidigm Corp.
- Illumina Inc.
- Merck Kgaa
- Promega Corp.
- Qiagen NV
- Thermo Fisher Scientific Inc.
List of Tables
Summary Table: Global Market for RNA Analysis/Transcriptomics, by Technology, Through 2026
Table 1: Global Market for RNA Analysis/Transcriptomics, Through 2026
Table 2: Global Market for RNA Analysis/Transcriptomics, by Technology, Through 2026
Table 3: Global Market for Polymerase Chain Reaction, Through 2026
Table 4: Global Market for Sequencing Technologies, Through 2026
Table 5: Global Market for Microarrays, Through 2026
Table 6: Global Market for RNAi Gene Silencing, Through 2026
Table 7: Global Market for RNA Analysis/Transcriptomics, by Application, Through 2026
Table 8: Global Market for RNA Analysis in Drug Discovery, Through 2026
Table 9: Global Market for RNA Analysis in Toxicogenomics, Through 2026
Table 10: Global Market for RNA Analysis in Clinical Diagnostics, Through 2026
Table 11: Global Market for RNA Analysis/Transcriptomics, by Region, Through 2026
Table 12: North American Market for RNA Analysis/Transcriptomics, by Technology, Through 2026
Table 13: North American Market for RNA Analysis/Transcriptomics, by Application, Through 2026
Table 14: European Market for RNA Analysis/Transcriptomics, by Technology, Through 2026
Table 15: European Market for RNA Analysis/Transcriptomics, by Application, Through 2026
Table 16: Asia-Pacific Market for RNA Analysis/Transcriptomics, by Technology, Through 2026
Table 17: Asia-Pacific Market for RNA Analysis/Transcriptomics, by Application, Through 2026
Table 18: South American Market for RNA Analysis/Transcriptomics, by Technology, Through 2026
Table 19: South American Market for RNA Analysis/Transcriptomics, by Application, Through 2026
Table 20: Middle East and African Market for RNA Analysis/Transcriptomics, by Technology, Through 2026
Table 21: Middle East and African Market for RNA Analysis/Transcriptomics, by Application, Through 2026
Table 22: Agilent Technologies Inc.: Products
Table 23: Agilent Technologies Inc.: Financial Performance, 2017–2020
Table 24: Bio-Rad Laboratories Inc.: Products
Table 25: Bio-Rad Laboratories Inc.: Financial Performance, 2017–2020
Table 26: CD Genomics: Products
Table 27: Danaher Corp.: Financial Performance, 2018–2020
Table 28: Eurofins Scientific: Products
Table 29: Eurofins Scientific: Financial Performance, 2019 and 2020
Table 30: Roche: Products
Table 31: Roche: Financial Performance, 2019 and 2020
Table 32: Fluidigm Corp.: Products
Table 33: Fluidigm Corp.: Financial Performance, 2018–2020
Table 34: Illumina Inc.: Products and Services
Table 35: Illumina Inc.: Financial Performance, 2018–2020
Table 36: Merck KGaA: Financial Performance, 2019 and 2020
Table 37: Promega Corp: Solutions
Table 38: Qiagen NV: Products
Table 39: Qiagen NV: Financial Performance, 2017–2020
Table 40: Thermo Fisher Scientific Inc.: Products
Table 41: Thermo Fisher Scientific Inc.: Financial Performance, 2017–2020
List of Figures
Summary Figure: Global Market for RNA Analysis/Transcriptomics, by Technology, 2019–2026
Figure 1: Global Market for RNA Analysis/Transcriptomics, 2019–2026
Figure 2: Global Market for Polymerase Chain Reaction, 2019–2026
Figure 3: Global Market for Sequencing Technologies, 2020–2026
Figure 4: Global Market for Microarrays, 2019–2026
Figure 5: Global Market for RNAi Gene Silencing, 2019–2026
Figure 6: Global Market for RNA Analysis in Drug Discovery, 2020–2026
Figure 7: Global Market for RNA Analysis in Toxicogenomics, 2019-2026
Figure 8: Global Market for RNA Analysis in Clinical Diagnostics, 2019–2026
Figure 9: Global Market Shares of RNA Analysis/Transcriptomics, by Region, 2020
Figure 10: Global Market Revenue Shares of RNA Analysis/Transcriptomics, by Company, 2020
Samples
LOADING...
Executive Summary
RNA analysis can reveal diseases and systems that contribute to death, and this type of analysis can be a useful tool in forensic pathology for determining the cause of death. RNA species (messenger RNA, transfer RNA, and ribosomal RNA) play an important role in the translation of genetic information from DNA to proteins. MicroRNA and other short, non-coding RNAs have lately been discovered to have new functions in gene regulation. From large-scale analyses of the transcriptome - the whole collection of RNA transcripts encoded by a genome - to exploring the actions of individual short, non-coding RNAs on specific genes, RNA analysis research encompasses a wide range of issues.
For gene expression analysis, RT-qPCR is a must-have tool. During an experiment, RT-qPCR devices are used to detect and monitor the expression of specific RNA targets in real-time.
RNases (RNA-degrading enzymes) are ubiquitous. It is crucial to successfully isolate RNA and keep it intact, especially when delicate downstream applications are involved (e.g., RNA sequencing). All RNA purification and handling should take place in a lab that is RNase-free and RNA-only, and gloves should be used at all times to avoid contamination. Using an RNase inhibitor to protect samples from RNase degradation is crucial.
This report explores the present and future market values of the RNA analysis market, particularly by type of analysis such as microarrays, polymerase chain reaction (PCR), sequencing technologies, and RNAi gene silencing. Market analysis for applications such as clinical diagnosis, drug discovery and toxicogenomics is also explored in the report.
Companies Mentioned
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- CD Genomics
- Danaher Corp.
- Eurofins Scientific
- F. Hoffmann-La Roche Ltd.
- Fluidigm Corp.
- Illumina Inc.
- Merck Kgaa
- Promega Corp.
- Qiagen NV
- Thermo Fisher Scientific Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 55 |
| Published | October 2021 |
| Forecast Period | 2021 - 2026 |
| Estimated Market Value ( USD | $ 8.3 Billion |
| Forecasted Market Value ( USD | $ 13.4 Billion |
| Compound Annual Growth Rate | 9.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
